Sökning: L773:2666 6375 OR L773:2666 6367 >
Interaction Between...
Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplantation
-
- Carreira, Abel Santos (författare)
- Univ Toronto, Dept Med, Sect Med Oncol & Hematol, Toronto, ON, Canada.;Univ Hlth Network, Princess Margaret Canc Ctr, Hans Messner Allogene Blood & Marrow Transplantat, Div Med Oncol & Hematol, Toronto, ON, Canada.
-
- Salas, Maria Queralt (författare)
- Univ Toronto, Dept Med, Sect Med Oncol & Hematol, Toronto, ON, Canada.;Univ Hlth Network, Princess Margaret Canc Ctr, Hans Messner Allogene Blood & Marrow Transplantat, Div Med Oncol & Hematol, Toronto, ON, Canada.;Hosp Clin Barcelona, Dept Hematol, Hematopoiet Cell Transplant Unit, IDIBAPS, Barcelona, Spain.
-
- Remberger, Mats, Professor, 1955- (författare)
- Uppsala universitet,Hematologi,Uppsala Univ Hosp, KFUE, Uppsala, Sweden.
-
visa fler...
-
- Novitzky-Basso, Igor (författare)
- Princess Margaret Hosp, Canc Ctr, Toronto, ON, Canada.
-
- Law, Arjun Datt (författare)
- Univ Toronto, Dept Med, Sect Med Oncol & Hematol, Toronto, ON, Canada.;Univ Hlth Network, Princess Margaret Canc Ctr, Hans Messner Allogene Blood & Marrow Transplantat, Div Med Oncol & Hematol, Toronto, ON, Canada.
-
- Lam, Wilson (författare)
- Univ Toronto, Dept Med, Sect Med Oncol & Hematol, Toronto, ON, Canada.;Univ Hlth Network, Princess Margaret Canc Ctr, Hans Messner Allogene Blood & Marrow Transplantat, Div Med Oncol & Hematol, Toronto, ON, Canada.
-
- Pasic, Ivan (författare)
- Univ Toronto, Dept Med, Sect Med Oncol & Hematol, Toronto, ON, Canada.;Univ Hlth Network, Princess Margaret Canc Ctr, Hans Messner Allogene Blood & Marrow Transplantat, Div Med Oncol & Hematol, Toronto, ON, Canada.
-
- Mazzulli, Tony (författare)
- Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.;Sinai Hlth Syst, Dept Microbiol, Univ Hlth Network, Toronto, ON, Canada.
-
- Cserti-Gazdewich, Christine (författare)
- Univ Toronto, Dept Med, Sect Med Oncol & Hematol, Toronto, ON, Canada.;Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.;Univ Hlth Network, Lab Med Program, Blood Transfus Lab, Toronto, ON, Canada.
-
- Kim, Dennis (Dong Hwan) (författare)
- Univ Toronto, Dept Med, Sect Med Oncol & Hematol, Toronto, ON, Canada.;Univ Hlth Network, Princess Margaret Canc Ctr, Hans Messner Allogene Blood & Marrow Transplantat, Div Med Oncol & Hematol, Toronto, ON, Canada.
-
- Michelis, Fotios, V (författare)
- Univ Toronto, Dept Med, Sect Med Oncol & Hematol, Toronto, ON, Canada.;Univ Hlth Network, Princess Margaret Canc Ctr, Hans Messner Allogene Blood & Marrow Transplantat, Div Med Oncol & Hematol, Toronto, ON, Canada.
-
- Viswabandya, Auro (författare)
- Univ Toronto, Dept Med, Sect Med Oncol & Hematol, Toronto, ON, Canada.;Univ Hlth Network, Princess Margaret Canc Ctr, Hans Messner Allogene Blood & Marrow Transplantat, Div Med Oncol & Hematol, Toronto, ON, Canada.
-
- Gerbitz, Armin (författare)
- Univ Toronto, Dept Med, Sect Med Oncol & Hematol, Toronto, ON, Canada.;Univ Hlth Network, Princess Margaret Canc Ctr, Hans Messner Allogene Blood & Marrow Transplantat, Div Med Oncol & Hematol, Toronto, ON, Canada.
-
- Lipton, Jeffrey Howard (författare)
- Univ Toronto, Dept Med, Sect Med Oncol & Hematol, Toronto, ON, Canada.;Univ Hlth Network, Princess Margaret Canc Ctr, Hans Messner Allogene Blood & Marrow Transplantat, Div Med Oncol & Hematol, Toronto, ON, Canada.
-
- Kumar, Rajat (författare)
- Univ Toronto, Dept Med, Sect Med Oncol & Hematol, Toronto, ON, Canada.;Univ Hlth Network, Princess Margaret Canc Ctr, Hans Messner Allogene Blood & Marrow Transplantat, Div Med Oncol & Hematol, Toronto, ON, Canada.
-
- Hassan, Moustapha (författare)
- Karolinska Institutet
-
- Mattsson, Jonas (författare)
- Karolinska Institutet
-
visa färre...
-
Univ Toronto, Dept Med, Sect Med Oncol & Hematol, Toronto, ON, Canada;Univ Hlth Network, Princess Margaret Canc Ctr, Hans Messner Allogene Blood & Marrow Transplantat, Div Med Oncol & Hematol, Toronto, ON, Canada. Univ Toronto, Dept Med, Sect Med Oncol & Hematol, Toronto, ON, Canada.;Univ Hlth Network, Princess Margaret Canc Ctr, Hans Messner Allogene Blood & Marrow Transplantat, Div Med Oncol & Hematol, Toronto, ON, Canada.;Hosp Clin Barcelona, Dept Hematol, Hematopoiet Cell Transplant Unit, IDIBAPS, Barcelona, Spain. (creator_code:org_t)
- Elsevier, 2023
- 2023
- Engelska.
-
Ingår i: Transplantation and Cellular Therapy. - : Elsevier. - 2666-6375 .- 2666-6367. ; 29:9, s. 581.e1-581.e8
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- This study investigates the incidence and predictors of hemorrhagic cystitis (HC) in 960 adults undergoing allo- hematopoietic stem cell transplantation. Two hundred fifty-two (26.5%) patients received myeloablative conditioning regimens, and 81.4% received high-dose intravenous busulfan (HD Bu). Six hundred ninety-five (72.4%) patients received post-transplantation cyclophosphamide (PTCY)-based prophylaxis, and 91.4% additionally received anti-thymocyte globulin (ATG) and Cyclosporine A (CsA) (PTCY-ATG-CsA). Two hundred twenty-eight (23.8%) patients developed HC. The day 100 cumulative incidences of grades 2-4 and 3-4 HC were 11.1% and 4.9%. BK virus was isolated in 58.3% of urinary samples. Using HD BU myeloablative regimens increased the risk for grade 2-4 HC (hazard ratio [HR] = 1.97, P = .035), and HD BU combined with ATG-PTCY-CsA increased this 4 times (HR = 4.06, P < .001) for grade 2-4 HC compared to patients who received neither of these drugs. A significant correlation was documented between grade II-IV acute graft-versus-host disease and grade 2-4 HC (HR = 2.10, P < .001). Moreover, patients with BK-POS grade 2-4 HC had lower 1-year overall survival (HR = 1.51, P = .009) and higher non-relapse mortality (HR = 2.31, P < .001), and patients with BK-NEG grade 2-4 HC had comparable post-transplantation outcomes. In conclusion, intravenous HD Bu was identified as a predictor for grade 2-4 HC. Moreover, when HD Bu was combined with PTCY-ATG-CsA, the risk increased 4-fold. Based on the results provided by this study, preventing the onset of HC, especially in high-risk patients, is mandatory because its presence significantly increases the risk for mortality.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Hematologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Hematology (hsv//eng)
Nyckelord
- Hemorrhagic cystitis
- PTCY
- Busulfan
- Allogeneic hematopoietic cell transplantation
- Quality of care
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Carreira, Abel S ...
-
Salas, Maria Que ...
-
Remberger, Mats, ...
-
Novitzky-Basso, ...
-
Law, Arjun Datt
-
Lam, Wilson
-
visa fler...
-
Pasic, Ivan
-
Mazzulli, Tony
-
Cserti-Gazdewich ...
-
Kim, Dennis (Don ...
-
Michelis, Fotios ...
-
Viswabandya, Aur ...
-
Gerbitz, Armin
-
Lipton, Jeffrey ...
-
Kumar, Rajat
-
Hassan, Moustaph ...
-
Mattsson, Jonas
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Hematologi
- Artiklar i publikationen
-
Transplantation ...
- Av lärosätet
-
Uppsala universitet
-
Karolinska Institutet